HCA Healthcare, Inc. (HCA) · Insider trading
What HCA Healthcare's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$31.12M
5 insiders, 0% under a plan
Net, 12 months
−$31.12M
bought less sold
Latest filing
2026-08-28
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Hazen Samuel NDirector, CEO | – | $21.48M | 7 | 2026-02-03 | 60,437 |
| Berres JenniferSVP & Chief Human Res. Officer | – | $7.20M | 4 | 2026-02-11 | 16,003 |
| Foster Jon MEVP and COO | – | $5.80M | 1 | 2025-05-13 | 12,646 |
| McAlevey Michael REVP & Chief Legal & Admin Off. | – | $2.75M | 2 | 2026-02-18 | 8,853 |
| Cuffe Michael S.EVP and Chief Clinical Officer | – | $2.35M | 2 | 2026-02-03 | 30,003 |
| Wyatt Christopher F.SVP & Controller | – | $2.02M | 1 | 2026-02-11 | 44,379 |
| Billington Phillip GSVP-Internal Audit Services | – | $1.36M | 1 | 2024-11-14 | 52,702 |
| Akdamar Erol RGroup President | – | $1.02M | 1 | 2024-11-14 | 6,843 |
| Whalen Kathleen MSVP & Chief Ethics Officer | – | $527,677 | 1 | 2024-11-14 | 9,454 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-18 | McAlevey Michael REVP & Chief Legal & Admin Off. | Sale | 1,694 | 533.37 | $903,529 | 8,853 | Form 4 |
| 2026-02-11 | Berres JenniferSVP & Chief Human Res. Officer | Sale | 4,010 | 503.00 | $2.02M | 16,003 | Form 4 |
| 2026-02-11 | Berres JenniferSVP & Chief Human Res. Officer | Sale | 4,010 | 526.16 | $2.11M | 11,993 | Form 4 |
| 2026-02-11 | Wyatt Christopher F.SVP & Controller | Sale | 4,000 | 505.00 | $2.02M | 44,379 | Form 4 |
| 2026-02-03 | Cuffe Michael S.EVP and Chief Clinical Officer | Sale | 1,500 | 498.09 | $747,135 | 30,003 | Form 4 |
| 2026-02-03 | Hazen Samuel NDirector, CEO | Sale | 14,716 | 502.95 | $7.40M | 60,437 | Form 4 |
| 2026-02-03 | Hazen Samuel NDirector, CEO | Sale | 5,002 | 502.15 | $2.51M | 55,435 | Form 4 |
| 2026-02-03 | Hazen Samuel NDirector, CEO | Sale | 7,395 | 500.69 | $3.70M | 48,040 | Form 4 |
| 2026-02-03 | Hazen Samuel NDirector, CEO | Sale | 6,189 | 500.02 | $3.09M | 41,851 | Form 4 |
| 2026-02-03 | Hazen Samuel NDirector, CEO | Sale | 5,162 | 498.80 | $2.57M | 36,689 | Form 4 |
| 2026-02-03 | Hazen Samuel NDirector, CEO | Sale | 4,293 | 498.12 | $2.14M | 32,396 | Form 4 |
| 2026-02-03 | Hazen Samuel NDirector, CEO | Sale | 120 | 497.18 | $59,662 | 32,276 | Form 4 |
| 2025-11-05 | McAlevey Michael REVP & Chief Legal & Admin Off. | Sale | 3,892 | 473.79 | $1.84M | 3,487 | Form 4 |
| 2025-09-08 | Cuffe Michael S.EVP and Chief Clinical Officer | Saleplan | 3,836 | 418.84 | $1.61M | 31,503 | Form 4 |
| 2025-05-13 | Foster Jon MEVP and COO | Sale | 15,698 | 369.32 | $5.80M | 12,646 | Form 4 |
| 2025-02-14 | Berres JenniferSVP & Chief Human Res. Officer | Sale | 4,155 | 322.96 | $1.34M | 20,790 | Form 4 |
| 2025-02-14 | Berres JenniferSVP & Chief Human Res. Officer | Sale | 5,378 | 322.31 | $1.73M | 15,412 | Form 4 |
| 2024-11-14 | Whalen Kathleen MSVP & Chief Ethics Officer | Sale | 1,474 | 357.99 | $527,677 | 9,454 | Form 4 |
| 2024-11-14 | Akdamar Erol RGroup President | Sale | 2,900 | 353.00 | $1.02M | 6,843 | Form 4 |
| 2024-11-14 | Billington Phillip GSVP-Internal Audit Services | Sale | 3,897 | 350.00 | $1.36M | 52,702 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
33 × grant or award29 × other29 × shares withheld for tax23 × gift14 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-26 | McAlevey Michael REVP & Chief Legal & Admin Off. | Other J | −7,769 | 429.00 | 0 | Form 4 |
| 2026-05-07 | Marks Mike AEVP and CFO | Gift G | −3,336 | – | 0 | Form 4 |
| 2026-05-07 | Marks Mike AEVP and CFO | Gift G | +3,336 | – | 46,576 | Form 4 |
| 2026-04-28 | Frist Thomas F IIIDirector, 10% owner | Grant or award A | +1,041 | – | 15,858 | Form 4 |
| 2026-04-28 | Frist William RDirector, 10% owner | Grant or award A | +809 | – | 13,740 | Form 4 |
| 2026-04-28 | Chidsey JohnDirector | Grant or award A | +809 | – | 1,305 | Form 4 |
| 2026-04-28 | Deparle Nancy AnnDirector | Grant or award A | +509 | – | 21,910 | Form 4 |
| 2026-04-28 | Johnston Hugh FDirector | Grant or award A | +809 | – | 4,475 | Form 4 |
| 2026-04-28 | Michelson Michael WDirector | Grant or award A | +925 | – | 12,576 | Form 4 |
| 2026-04-28 | Riley Wayne JosephDirector | Grant or award A | +509 | – | 15,029 | Form 4 |
| 2026-04-28 | Smith Andrea BDirector | Grant or award A | +509 | – | 4,666 | Form 4 |
| 2026-02-13 | McAlevey Michael REVP & Chief Legal & Admin Off. | Option exercise M | +5,000 | 236.61 | 13,853 | Form 4 |
| 2026-02-13 | McAlevey Michael REVP & Chief Legal & Admin Off. | Shares withheld for tax F | −3,306 | 540.29 | 10,547 | Form 4 |
| 2026-02-10 | Berres JenniferSVP & Chief Human Res. Officer | Grant or award A | +7,116 | – | 22,528 | Form 4 |
| 2026-02-10 | Berres JenniferSVP & Chief Human Res. Officer | Shares withheld for tax F | −2,515 | 502.05 | 20,013 | Form 4 |
| 2026-02-10 | Cuffe Michael S.EVP and Chief Clinical Officer | Grant or award A | +9,628 | – | 35,581 | Form 4 |
| 2026-02-10 | Cuffe Michael S.EVP and Chief Clinical Officer | Shares withheld for tax F | −3,501 | 502.05 | 32,080 | Form 4 |
| 2026-02-10 | Foster Jon MEVP and COO | Grant or award A | +15,696 | – | 28,950 | Form 4 |
| 2026-02-10 | Foster Jon MEVP and COO | Shares withheld for tax F | −5,888 | 502.05 | 23,062 | Form 4 |
| 2026-02-10 | Hazen Samuel NDirector, CEO | Grant or award A | +54,934 | – | 86,165 | Form 4 |
| 2026-02-10 | Hazen Samuel NDirector, CEO | Shares withheld for tax F | −21,323 | 502.05 | 64,842 | Form 4 |
| 2026-02-10 | Marks Mike AEVP and CFO | Grant or award A | +5,026 | – | 5,026 | Form 4 |
| 2026-02-10 | Marks Mike AEVP and CFO | Shares withheld for tax F | −1,690 | 502.05 | 3,336 | Form 4 |
| 2026-02-10 | McAlevey Michael REVP & Chief Legal & Admin Off. | Grant or award A | +8,372 | – | 11,859 | Form 4 |
| 2026-02-10 | McAlevey Michael REVP & Chief Legal & Admin Off. | Shares withheld for tax F | −3,006 | 502.05 | 8,853 | Form 4 |
| 2026-02-10 | Rossitto EricaSVP & Chief Nurse Executive | Grant or award A | +1,676 | – | 10,825 | Form 4 |
| 2026-02-10 | Rossitto EricaSVP & Chief Nurse Executive | Shares withheld for tax F | −418 | 502.05 | 10,407 | Form 4 |
| 2026-02-10 | Wyatt Christopher F.SVP & Controller | Grant or award A | +3,350 | – | 49,413 | Form 4 |
| 2026-02-10 | Wyatt Christopher F.SVP & Controller | Shares withheld for tax F | −1,034 | 502.05 | 48,379 | Form 4 |
| 2026-02-06 | Frisco Holding II10% owner | Other J | −36,629,188 | – | 0 | Form 4 |
| 2026-02-06 | Frisco Holding II10% owner | Other J | +36,557,141 | – | 36,557,141 | Form 4 |
| 2026-02-06 | Hercules Holding II10% owner | Other J | −36,629,188 | – | 32,282,889 | Form 4 |
| 2026-02-06 | Elcan Patricia F10% owner | Other J | −36,629,188 | – | 0 | Form 4 |
| 2026-02-06 | Elcan Patricia F10% owner | Other J | +36,557,141 | – | 36,557,141 | Form 4 |
| 2026-02-06 | Frist Thomas F IIIDirector, 10% owner | Other J | −36,629,188 | – | 0 | Form 4 |
| 2026-02-06 | Frist Thomas F IIIDirector, 10% owner | Other J | +36,557,141 | – | 36,557,141 | Form 4 |
| 2026-02-06 | Frist William RDirector, 10% owner | Other J | −36,629,188 | – | 0 | Form 4 |
| 2026-02-06 | Frist William RDirector, 10% owner | Other J | +36,557,141 | – | 36,557,141 | Form 4 |
| 2026-02-06 | Frist Thomas F Jr10% owner | Other J | −36,629,188 | – | 0 | Form 4 |
| 2026-02-06 | Frist Thomas F Jr10% owner | Other J | +36,557,141 | – | 36,557,141 | Form 4 |
| 2026-02-05 | Foster Jon MEVP and COO | Option exercise M | +29,330 | 139.06 | 29,330 | Form 4 |
| 2026-02-05 | Foster Jon MEVP and COO | Shares withheld for tax F | −16,076 | 513.76 | 13,254 | Form 4 |
| 2026-02-05 | Wyatt Christopher F.SVP & Controller | Option exercise M | +10,670 | 139.06 | 51,737 | Form 4 |
| 2026-02-05 | Wyatt Christopher F.SVP & Controller | Shares withheld for tax F | −5,674 | 513.76 | 46,063 | Form 4 |
| 2026-02-04 | Hazen Samuel NDirector, CEO | Other J | −1,045 | 498.35 | 31,231 | Form 4 |
| 2026-02-04 | Hazen Samuel NDirector, CEO | Other J | +1,045 | 498.35 | 16,024 | Form 4 |
| 2026-02-03 | Cuffe Michael S.EVP and Chief Clinical Officer | Gift G | −4,050 | – | 25,953 | Form 4 |
| 2026-01-30 | Hazen Samuel NDirector, CEO | Option exercise M | +84,360 | 81.96 | 116,636 | Form 4 |
| 2026-01-30 | Hazen Samuel NDirector, CEO | Shares withheld for tax F | −41,483 | 488.27 | 75,153 | Form 4 |
| 2025-11-14 | Hazen Samuel NDirector, CEO | Gift G | −14,830 | – | 32,276 | Form 4 |
| 2025-11-05 | Marks Mike AEVP and CFO | Gift G | −165 | – | 0 | Form 4 |
| 2025-11-03 | Marks Mike AEVP and CFO | Gift G | −165 | – | 43,240 | Form 4 |
| 2025-11-03 | Marks Mike AEVP and CFO | Gift G | +165 | – | 165 | Form 4 |
| 2025-11-03 | McAlevey Michael REVP & Chief Legal & Admin Off. | Option exercise M | +13,170 | 236.61 | 16,657 | Form 4 |
| 2025-11-03 | McAlevey Michael REVP & Chief Legal & Admin Off. | Shares withheld for tax F | −9,278 | 461.56 | 7,379 | Form 4 |
| 2025-10-31 | Hazen Samuel NDirector, CEO | Option exercise M | +58,050 | 69.58 | 75,279 | Form 4 |
| 2025-10-31 | Hazen Samuel NDirector, CEO | Shares withheld for tax F | −28,173 | 459.68 | 47,106 | Form 4 |
| 2025-09-04 | Cuffe Michael S.EVP and Chief Clinical Officer | Option exercise M | +10,920 | 173.12 | 42,423 | Form 4 |
| 2025-09-04 | Cuffe Michael S.EVP and Chief Clinical Officer | Shares withheld for tax F | −7,084 | 411.59 | 35,339 | Form 4 |
| 2025-07-29 | Chidsey JohnDirector | Grant or award A | +496 | – | 496 | Form 4 |
| 2025-05-13 | Foster Jon MEVP and COO | Gift G | −1,080 | – | 11,566 | Form 4 |
| 2025-05-13 | Foster Jon MEVP and COO | Gift G | +1,080 | – | 67,595 | Form 4 |
| 2025-05-13 | Foster Jon MEVP and COO | Gift G | −2,075 | – | 15,925 | Form 4 |
| 2025-05-13 | Foster Jon MEVP and COO | Gift G | +2,075 | – | 56,383 | Form 4 |
| 2025-05-13 | Foster Jon MEVP and COO | Other J | −15,925 | 367.20 | 0 | Form 4 |
| 2025-05-13 | Foster Jon MEVP and COO | Other J | +15,925 | 367.20 | 72,308 | Form 4 |
| 2025-05-13 | Hazen Samuel NDirector, CEO | Gift G | −90,076 | – | 0 | Form 4 |
| 2025-05-13 | Hazen Samuel NDirector, CEO | Gift G | +90,076 | – | 93,088 | Form 4 |
| 2025-05-07 | Marks Mike AEVP and CFO | Gift G | −181 | – | 285 | Form 4 |
| 2025-05-07 | Marks Mike AEVP and CFO | Gift G | +181 | – | 43,120 | Form 4 |
| 2025-05-07 | Marks Mike AEVP and CFO | Other J | −285 | 356.84 | 0 | Form 4 |
| 2025-05-07 | Marks Mike AEVP and CFO | Other J | +285 | 356.84 | 43,405 | Form 4 |
| 2025-05-07 | Marks Mike AEVP and CFO | Gift G | −144 | – | 0 | Form 4 |
| 2025-05-06 | Marks Mike AEVP and CFO | Gift G | −466 | – | 0 | Form 4 |
| 2025-05-06 | Marks Mike AEVP and CFO | Gift G | +466 | – | 466 | Form 4 |
| 2025-05-06 | Marks Mike AEVP and CFO | Other J | −288 | 353.58 | 42,939 | Form 4 |
| 2025-05-06 | Marks Mike AEVP and CFO | Other J | +288 | 353.58 | 288 | Form 4 |
| 2025-05-06 | Marks Mike AEVP and CFO | Gift G | −144 | – | 144 | Form 4 |
| 2025-04-30 | Frist William RDirector, 10% owner | Other J | +10,505 | 340.60 | 1,574,897 | Form 4 |
| 2025-04-29 | Dennis Robert JDirector | Grant or award A | +1,026 | – | 26,601 | Form 4 |
| 2025-04-29 | Deparle Nancy AnnDirector | Grant or award A | +645 | – | 21,401 | Form 4 |
| 2025-04-29 | Johnston Hugh FDirector | Grant or award A | +1,026 | – | 3,666 | Form 4 |
| 2025-04-29 | Michelson Michael WDirector | Grant or award A | +1,173 | – | 11,651 | Form 4 |
| 2025-04-29 | Riley Wayne JosephDirector | Grant or award A | +645 | – | 14,520 | Form 4 |
| 2025-04-29 | Smith Andrea BDirector | Grant or award A | +645 | – | 4,157 | Form 4 |
| 2025-04-29 | Frist Thomas F IIIDirector, 10% owner | Grant or award A | +1,320 | – | 14,817 | Form 4 |
| 2025-04-29 | Frist William RDirector, 10% owner | Grant or award A | +1,026 | – | 12,931 | Form 4 |
| 2025-02-13 | Berres JenniferSVP & Chief Human Res. Officer | Grant or award A | +1,588 | – | 25,352 | Form 4 |
| 2025-02-13 | Berres JenniferSVP & Chief Human Res. Officer | Shares withheld for tax F | −407 | 321.92 | 24,945 | Form 4 |
| 2025-02-13 | Cuffe Michael S.EVP and Chief Clinical Officer | Grant or award A | +2,330 | – | 32,008 | Form 4 |
| 2025-02-13 | Cuffe Michael S.EVP and Chief Clinical Officer | Shares withheld for tax F | −583 | 321.92 | 31,425 | Form 4 |
| 2025-02-13 | Foster Jon MEVP and COO | Grant or award A | +2,750 | – | 29,028 | Form 4 |
| 2025-02-13 | Foster Jon MEVP and COO | Shares withheld for tax F | −684 | 321.92 | 28,344 | Form 4 |
| 2025-02-13 | Hazen Samuel NDirector, CEO | Grant or award A | +13,218 | – | 76,418 | Form 4 |
| 2025-02-13 | Hazen Samuel NDirector, CEO | Shares withheld for tax F | −4,742 | 321.92 | 71,676 | Form 4 |
| 2025-02-13 | Marks Mike AEVP and CFO | Grant or award A | +638 | – | 638 | Form 4 |
| 2025-02-13 | Marks Mike AEVP and CFO | Shares withheld for tax F | −172 | 321.92 | 466 | Form 4 |
| 2025-02-13 | McAlevey Michael REVP & Chief Legal & Admin Off. | Grant or award A | +2,117 | – | 3,227 | Form 4 |
| 2025-02-13 | McAlevey Michael REVP & Chief Legal & Admin Off. | Shares withheld for tax F | −531 | 321.92 | 2,696 | Form 4 |
| 2025-02-13 | Mosier Sammie SSVP & Chief Nurse Executive | Grant or award A | +845 | – | 11,340 | Form 4 |
| 2025-02-13 | Mosier Sammie SSVP & Chief Nurse Executive | Shares withheld for tax F | −227 | 321.92 | 11,113 | Form 4 |
| 2025-02-13 | Wyatt Christopher F.SVP & Controller | Grant or award A | +845 | – | 41,294 | Form 4 |
| 2025-02-13 | Wyatt Christopher F.SVP & Controller | Shares withheld for tax F | −227 | 321.92 | 41,067 | Form 4 |
| 2025-02-07 | Berres JenniferSVP & Chief Human Res. Officer | Option exercise M | +7,440 | 101.16 | 26,171 | Form 4 |
| 2025-02-07 | Berres JenniferSVP & Chief Human Res. Officer | Option exercise M | +4,340 | 139.06 | 30,511 | Form 4 |
| 2025-02-07 | Berres JenniferSVP & Chief Human Res. Officer | Shares withheld for tax F | −6,747 | 322.05 | 23,764 | Form 4 |
| 2025-02-03 | Mosier Sammie SSVP & Chief Nurse Executive | Option exercise M | +138 | – | 10,536 | Form 4 |
| 2025-02-03 | Mosier Sammie SSVP & Chief Nurse Executive | Shares withheld for tax F | −41 | 334.30 | 10,495 | Form 4 |
| 2024-11-14 | Foster Jon MEVP and COO | Other J | −9,502 | 352.74 | 30,535 | Form 4 |
| 2024-11-14 | Foster Jon MEVP and COO | Other J | +9,502 | 352.74 | 64,560 | Form 4 |
| 2024-11-14 | Foster Jon MEVP and COO | Gift G | −1,955 | – | 28,580 | Form 4 |
| 2024-11-14 | Foster Jon MEVP and COO | Gift G | +1,955 | – | 66,515 | Form 4 |
| 2024-11-14 | Foster Jon MEVP and COO | Gift G | −18,000 | – | 10,580 | Form 4 |
| 2024-11-14 | Foster Jon MEVP and COO | Gift G | +18,000 | – | 18,000 | Form 4 |
| 2024-11-14 | Foster Jon MEVP and COO | Option exercise M | +36,600 | 101.16 | 47,180 | Form 4 |
| 2024-11-14 | Foster Jon MEVP and COO | Shares withheld for tax F | −20,902 | 345.51 | 26,278 | Form 4 |
| 2024-11-12 | Akdamar Erol RGroup President | Option exercise M | +20,000 | 68.96 | 20,000 | Form 4 |
| 2024-11-12 | Akdamar Erol RGroup President | Shares withheld for tax F | −10,257 | 350.53 | 9,743 | Form 4 |
| 2024-11-12 | Billington Phillip GSVP-Internal Audit Services | Option exercise M | +8,000 | 68.96 | 60,702 | Form 4 |
| 2024-11-12 | Billington Phillip GSVP-Internal Audit Services | Shares withheld for tax F | −4,103 | 350.53 | 56,599 | Form 4 |
| 2024-11-11 | Whalen Kathleen MSVP & Chief Ethics Officer | Option exercise M | +4,710 | 173.12 | 14,164 | Form 4 |
| 2024-11-11 | Whalen Kathleen MSVP & Chief Ethics Officer | Shares withheld for tax F | −3,236 | 357.99 | 10,928 | Form 4 |
| 2024-10-30 | Elcan Patricia F10% owner | Other J | −244,626 | 361.55 | 404,512 | Form 4 |
| 2024-10-30 | Elcan Patricia F10% owner | Other J | −138,000 | 361.55 | 638,574 | Form 4 |
| 2024-10-30 | Elcan Patricia F10% owner | Other J | −638,574 | 361.55 | 0 | Form 4 |
| 2024-10-30 | Elcan Patricia F10% owner | Other J | +138,000 | 361.55 | 264,217 | Form 4 |
| 2024-10-30 | Elcan Patricia F10% owner | Other J | +244,626 | 361.55 | 9,029,962 | Form 4 |
| 2024-10-30 | Elcan Patricia F10% owner | Other J | +638,574 | 361.55 | 9,668,536 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.